Weekly Quick Hits (BHCR) – Week of July 24, 2023

Published on : Published by : Mark Terry

Children’s Cancer Foundation Awards went out to 11 pediatric cancer researchers in the Baltimore-Washington region, and a number of companies reported their quarterly finances. It was a busy week for life science news in the Capital Region. Here’s a look.

Weekly Quick Hits (BioHealth Capital Region) – Week of July 17, 2023

Published on : Published by : Alex Keown

A strong revenue stream is essential for thriving biopharma companies. Despite a struggling economy, several companies within the BioHealth Capital Region are successfully raising capital to support development of new therapeutics for multiple disorders, while others continue to advance their own experimental assets. 

Central Virginia Launches New ‘Cluster Accelerator’ Plan to Fast-track Development of Advanced Pharmaceutical Manufacturing

Published on : Published by : BioBuzz Media

Activation Capital, a leading entrepreneurship and ecosystem development organization, announced the launch of a cluster accelerator to catalyze the growth of advanced pharmaceutical manufacturing and R&D in Central Virginia. A coalition of private-public entities from Greater Petersburg and Greater Richmond helped form the accelerator, secured $2.5M in seed funding from GO Virginia and others, and appointed Activation Capital as the organizing entity – a first-of-its-kind initiative for the Commonwealth of Virginia.

Virginia Life Sciences Ecosystem Gets Boost from Essential Medicines-Focused Phlow, Civica Rx

Published on : Published by : Alex Keown

The ongoing COVID-19 pandemic greatly exposed a dearth of essential medications and significant vulnerabilities in the United States medical supply chain. Phlow Corporation aims to mitigate those weaknesses and manufacture essential generic medications at its Virginia manufacturing facility.